To provide the best care for injured service members, combat medics need reliable tools. To develop better tools, they call upon engineers.
Combination of dasatinib and blinatumomab offers effective treatment for older Ph+ ALL patients
Older patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) who were not good candidates for the standard treatment of intensive chemotherapy had a median